Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Katerina Argyropoulou



I joined the Oncology Clinical Trials Office (OCTO) as Data Manager in March 2012. Prior to this I was a Data Manager at the Early Phase Clinical Trials Unit. Before coming to the UK I was leaving in Greece, there  I was teaching statistics at Vocational Training Institutes and I was as a consultant for the statistical analysis of medical data .

I am currently working on 3 different oncology studies:

SCALOP-2- A multi- centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer.

CHARIOT- A phase I dose escalation safety study combining the ART inhibitor M6620 (Berzosertib) with chemoradiotherapy in oesophageal cancer & other solid cancers using time to event continual reassessment method.

OxPLoreD- Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception study.